Showing results (391-400 of 530) with videos related to

Sort By:
Pageof 53
The Journal of Clinical Investigation|December 3, 1998
Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2D W Thomas, R B Mannon, P J Mannon, et al.
The Australian and New Zealand Journal of Surgery|December 1, 1987
Evaluation of an immunochemical test for faecal occult blood in screening for colorectal neoplasia in a high risk groupJ A Williams, R Hunter, D W Thomas, et al.
BMC Medicine|March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Journal of Clinical Microbiology|September 9, 2011
Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatmentIsobella Honeyborne, Timothy D McHugh, Patrick P J Phillips, et al.
Physical Review Letters|November 13, 2007
Benchmarking of electro-optic monitors for femtosecond electron bunchesG Berden, W A Gillespie, S P Jamison, et al.
Plos One|April 8, 2016
The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, RussiaPlaton Eliseev, Grigory Balantcev, Elena Nikishova, et al.
Physiological Measurement|December 31, 1997
The performance of an infra-red interactance instrument for assessing total body fatD W Thomas, S J Ryde, P A Ali, et al.
Pilot and Feasibility Studies|April 3, 2023
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in TanzaniaStellah G Mpagama, Happiness C Mvungi, Peter M Mbelele, et al.
BMC Medicine|May 22, 2018
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosisS E Murthy, F Chatterjee, A Crook, et al.
Open Forum Infectious Diseases|November 25, 2024
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in UgandaJillian L Kadota, Allan Musinguzi, Hélène E Aschmann, et al.
Pageof 53